TCS NEXUS S.L. supplies cosmetic peptide raw materials and selected actives to formulators, contract manufacturers, and skincare brands across Europe. Product-specific documentation, quality data, and regulatory review can be discussed according to the ingredient, intended market, and project stage. Stock position, packaging format, and lead time are confirmed from Valencia, Spain, according to current availability and destination.
Our catalogue supports expression-line, firming, brightening, eye-area, hair, and barrier-support development work. It includes cosmetic peptides such as GHK-Cu, Acetyl Hexapeptide-8, Palmitoyl Tripeptide-5, and Nonapeptide-1, together with selected complementary actives such as Ectoin, Ergothioneine, Glutathione, and Carnosine.
Sample review, packaging format, and project quantities confirmed on request
|
EU-focused supply from Valencia, with lead time confirmed by stock position and destination
|
COA, TDS, and SDS available according to product scope
|
Custom synthesis →
| S/N | Product Name | Sequence | CAS No. | HPLC | Details |
| 1 | Mu-conotoxin | Pyr-Gly-Cys-Cys-Asn-Gly-Pro-Lys-Gly-Cys-Ser-Ser- Lys-Trp-Cys-Arg-Asp-His-Ala-Arg-Cys-Cys-CONH2 | 936616-33-0 | ≥95% | Details |
| 2 | Dipeptide Diaminobutyroyl Benzylamide Diacetate (SYN-AKE) | β-Ala-Pro-Dab-NHBzl | 823202-99-9 | ≥98% | Details |
| 3 | Acetyl Hexapeptide-8 (Argireline) | Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2 | 616204-22-9 | ≥99% | Details |
| 4 | Hydroxypropyl Tetrahyclropyantiol | — | 439685-79-7 | ≥98% | Details |
| 5 | Tripeptide-1 (HOAc) | Gly-His-Lys (HOAc) | 72957-37-0 | ≥98% | Details |
| 6 | Tripeptide-1 (HCl) | Gly-His-Lys (HCl) | 72957-37-0 | ≥98% | Details |
| 7 | Copper Tripeptide-1 (GHK-Cu) – 1:1 HOAc | Gly-His-Lys:Cu (1:1, HOAc) | 89030-95-5 | ≥99% | Details |
| 8 | Copper Tripeptide-1 (GHK-Cu) – 1:1 HCl | Gly-His-Lys:Cu (1:1, HCl) | 89030-95-5 | ≥99% | Details |
| 9 | Copper Tripeptide-1 (GHK-Cu) – 2:1 HOAc | Gly-His-Lys:Cu (2:1, HOAc) | 130120-57-9 | ≥98% | Details |
| 10 | Glutathione | γ-Glu-Cys-Gly | 70-18-8 | ≥98% | Details |
| 11 | Nonapeptide-1 (Melanostatin) | Met-Pro-D-Phe-Arg-D-Trp-Phe-Lys-Pro-Val-NH2 | 158563-45-2 | ≥99% | Details |
| 12 | Ergothioneine | — | 497-30-3 | ≥98% | Details |
| 13 | L-Carnosine | β-Ala-His | 305-84-0 | ≥98.5% | Details |
| 14 | Decarboxy | — | 57022-38-5 | ≥98% | Details |
| 15 | Carnosine HCl | — | — | — | Details |
| 16 | N-Acetyl Carnosine | Ac-β-Ala-His | 56353-15-2 | ≥98% | Details |
| 17 | Ectoin | (S)-2-Methyl-1,4,5,6-tetrahydropyrimidine-4-carboxylic acid | 96702-03-3 | ≥98% | Details |
| 18 | Acetyl Tetrapeptide-5 (Eyeseryl) | Ac-β-Ala-His-Ser-His | 820959-17-9 | ≥98% | Details |
| 19 | Glutathione (Oxidized) GSSG | GSSG | 27025-41-8 | ≥98% | Details |
| 20 | Palmitoyl Tripeptide-1 (Kollaren) | Pal-Gly-His-Lys | 147732-56-7 | ≥98% | Details |
| 21 | Palmitoyl Tripeptide-5 (Syn-Coll) | Pal-Lys-Val-Lys | 623172-56-5 | ≥99% | Details |
| 22 | Palmitoyl Pentapeptide-4/3 (Matrixyl) | Pal-Lys-Thr-Thr-Lys-Ser | 214047-00-4 | ≥98% | Details |
| 23 | Tetrapeptide-3 | Lys-Gly-His-Lys-NH2 | 827306-97-8 | ≥98% | Details |
| 24 | Pentapeptide-1 | Arg-Lys-Asp-Val-Tyr | 69558-55-0 | ≥99% | Details |
| 25 | Pentapeptide-3 | Gly-Pro-Arg-Pro-Ala-NH2 | 135679-88-8 | ≥99% | Details |
| 26 | Pentapeptide-18 (Leuphasyl) | Tyr-D-Ala-Gly-Phe-Leu | 64963-01-5 | ≥98% | Details |
| 27 | Hexapeptide-3 | H-Glu-Glu-Met-Gln-Arg-Arg-NH2 | — | ≥98% | Details |
| 28 | Hexapeptide-9 | Gly-Pro-Gln-Gly-Pro-Gln | 1228371-11-6 | ≥98% | Details |
| 29 | Hexapeptide-11 | Phe-Val-Ala-Pro-Phe-Pro | 161258-30-6 | ≥98% | Details |
| 30 | Acetyl Tetrapeptide-9 (Dermican) | Ac-Gln-Asp-Val-His | 928006-50-2 | ≥98% | Details |
| 31 | Acetyl Tetrapeptide-11 | Ac-Pro-Pro-Tyr-Leu | 928006-88-6 | ≥98% | Details |
| 32 | Acetyl Pentapeptide-1 | Ac-Arg-Lys-Asp-Val-Tyr | — | ≥98% | Details |
| 33 | Acetyl Octapeptide-3/1 | Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2 | 868844-74-0 | ≥99% | Details |
| 34 | Acetyl Decapeptide-3 | Ac-Tyr-Arg-Ser-Arg-Lys-Tyr-Thr-Ser-Trp-Tyr-NH2 | 935288-50-9 | ≥98% | Details |
| 35 | Palmitoyl Hexapeptide-12 | Pal-Val-Gly-Val-Ala-Pro-Gly | 171263-26-6 | ≥98% | Details |
| 36 | Tripeptide-10 Citrulline | H-Lys-Asp-Ile-Cit-NH2 | 960531-53-7 | ≥98% | Details |
| 37 | Palmitoyl Tetrapeptide-7 (Rigin) | Pal-Gly-Gln-Pro-Arg | 221227-05-0 | ≥99% | Details |
| 38 | Acetyl Dipeptide-1 Cetyl Ester (Calmosensine) | Ac-Tyr-Arg-O-hexadecyl ester | 196604-48-5 | ≥98% | Details |
| 39 | Acetyl Tetrapeptide-15 | Ac-Tyr-Pro-Phe-Phe-NH2 | 928007-64-1 | ≥98% | Details |
| 40 | Decapeptide-4 | Gly-Glu-Pro-Pro-Pro-Gly-Arg-Pro-Ala-Asp | — | ≥98% | Details |
| 41 | Palmitoyl Tripeptide-8 (Neutrazen) | Pal-His-D-Phe-Arg-NH2 | 936544-53-5 | ≥98% | Details |
| 42 | Hexapeptide-2 | His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 | — | ≥98% | Details |
| 43 | Tetrapeptide-30 | PKEK | 1036207-61-0 | ≥98% | Details |
| 44 | L-Balenine | β-Ala-His(1-Me) | 331-38-4 | ≥98% | Details |
| 45 | L-Anserine | β-Ala-His(3-Me) | 584-85-0 | ≥98% | Details |
| 46 | Palmitoyl Tetrapeptide-10 | Pal-Lys-Thr-Phe-Lys | 887140-79-6 | ≥98% | Details |
| 47 | Biotinoyl Tripeptide-1 | Biotin-Gly-His-Lys | 299157-54-3 | ≥98% | Details |
| 48 | Acetyl Tetrapeptide-3 | Ac-Lys-Gly-His-Lys-NH2 | 827306-88-7 | ≥98% | Details |
| 49 | Myristoyl Pentapeptide-4 | Myr-Lys-Thr-Thr-Lys-Ser | — | ≥98% | Details |
| 50 | Myristoyl Pentapeptide-17 | Myr-Lys-Leu-Ala-Lys-Lys-NH2 | 959610-30-1 | ≥98% | Details |
| 51 | Myristoyl Hexapeptide-16 | Myr-AKLAKL-NH2 | 959610-54-9 | ≥95% | Details |
| 52 | Myristoyl Tetrapeptide-12 | Myr-Lys-Ala-Lys-Ala-NH2 | 959610-24-3 | ≥98% | Details |
| 53 | Dipeptide-2 | Val-Trp | 24587-37-9 | ≥99% | Details |
| 54 | Acetyl Hexapeptide-38 | Ac-Ser-Val-Val-Val-Arg-Thr-NH2 | 1400634-44-7 | ≥99% | Details |